Ng George K 4
4 · Processa Pharmaceuticals, Inc. · Filed Aug 9, 2023
Insider Transaction Report
Form 4
Ng George K
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Units
2023-08-08+400,000→ 400,000 totalExercise: $0.00→ Common Stock (400,000 underlying) - Award
Restricted Stock Units
2023-08-08+400,000→ 800,000 totalExercise: $0.00→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of one-third on 08/08/24, 08/08/25, and 08/08/26 or upon a change in control event.
- [F2]The restricted stock units vest upon the achievement of certain performance goals.